1. Home
  2. HAE vs CATY Comparison

HAE vs CATY Comparison

Compare HAE & CATY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HAE
  • CATY
  • Stock Information
  • Founded
  • HAE 1971
  • CATY 1962
  • Country
  • HAE United States
  • CATY United States
  • Employees
  • HAE N/A
  • CATY N/A
  • Industry
  • HAE Medical/Dental Instruments
  • CATY Major Banks
  • Sector
  • HAE Health Care
  • CATY Finance
  • Exchange
  • HAE Nasdaq
  • CATY Nasdaq
  • Market Cap
  • HAE 3.3B
  • CATY 3.3B
  • IPO Year
  • HAE 1991
  • CATY N/A
  • Fundamental
  • Price
  • HAE $54.81
  • CATY $45.19
  • Analyst Decision
  • HAE Strong Buy
  • CATY Hold
  • Analyst Count
  • HAE 10
  • CATY 6
  • Target Price
  • HAE $97.40
  • CATY $49.50
  • AVG Volume (30 Days)
  • HAE 736.1K
  • CATY 470.4K
  • Earning Date
  • HAE 08-07-2025
  • CATY 07-22-2025
  • Dividend Yield
  • HAE N/A
  • CATY 3.03%
  • EPS Growth
  • HAE 46.89
  • CATY N/A
  • EPS
  • HAE 3.28
  • CATY 4.14
  • Revenue
  • HAE $1,346,046,000.00
  • CATY $704,760,000.00
  • Revenue This Year
  • HAE N/A
  • CATY $17.34
  • Revenue Next Year
  • HAE $7.26
  • CATY $6.61
  • P/E Ratio
  • HAE $16.98
  • CATY $10.84
  • Revenue Growth
  • HAE 0.91
  • CATY N/A
  • 52 Week Low
  • HAE $55.30
  • CATY $36.06
  • 52 Week High
  • HAE $94.99
  • CATY $55.29
  • Technical
  • Relative Strength Index (RSI)
  • HAE 19.14
  • CATY 39.82
  • Support Level
  • HAE $73.49
  • CATY $44.65
  • Resistance Level
  • HAE $76.84
  • CATY $46.08
  • Average True Range (ATR)
  • HAE 2.64
  • CATY 1.03
  • MACD
  • HAE -2.11
  • CATY -0.36
  • Stochastic Oscillator
  • HAE 1.34
  • CATY 20.37

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

About CATY Cathay General Bancorp

Cathay General Bancorp is a regional bank predominantly serving the Chinese-American community. The company's policy is to reach out and actively offer services to low-to-moderate income groups in the delineated branch service areas. It predominantly provides services such as checking and deposit, lines of credits, commercial and commercial real estate loans, merchant services and payment processing, treasury management services, international banking and financing services, and other customary banking services to individuals, professionals, and small to medium-sized businesses. Through its Wealth Management unit, the company also offers investment products and services, such as stocks, bonds, mutual funds, insurance, annuities and advisory services.

Share on Social Networks: